Drug profile · INN
verapamil
ANPEC 80
verapamil (ANPEC 80) is a voltage-gated l-type calcium channel blocker. Associated with Alphapharm Pty Ltd.
TGA: approved NMPA: clinical trials
Patents linked 0
Pipeline programs 4
News articles 1
Drug details — verapamil
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 4
- Data quality
- 0.81
Quick answer
verapamil (ANPEC 80) is a voltage-gated l-type calcium channel blocker. Associated with Alphapharm Pty Ltd.
Key facts
INN verapamil
Brand ANPEC 80
Mechanism Voltage-gated L-type calcium channel blocker
Originator Alphapharm Pty Ltd
Mechanism of action
Voltage-gated L-type calcium channel blocker
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
| NMPA | clinical trials | — |
Recent coverage
Pipeline programs
Frequently asked questions
What is verapamil?
verapamil (ANPEC 80) is a voltage-gated l-type calcium channel blocker. Associated with Alphapharm Pty Ltd.
What is the brand name for verapamil?
ANPEC 80 is a marketed brand name for verapamil. Check FDA Drugs@FDA for the current US label holder and prescribing information.